These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Pearson TC; Hamano K; Morris PJ; Wood KJ Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480 [No Abstract] [Full Text] [Related]
5. A novel series of low molecular weight immunosuppressive agents. Ocain TD; Bastos CM; Gordon KA; Granstein RD; Jenson JC; Jones B; McAuliffe DJ; Newcomb JR Transplant Proc; 1996 Dec; 28(6):3032-4. PubMed ID: 8962176 [No Abstract] [Full Text] [Related]
6. The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody. Pearson TC; Madsen JC; Morris PJ; Wood KJ Transplant Proc; 1990 Aug; 22(4):1955-6. PubMed ID: 2389494 [No Abstract] [Full Text] [Related]
7. [Available methods to modify primary graft rejection (author's transl)]. Prange CH; Kliems G Wien Klin Wochenschr; 1977 Jul; 89(14):465-74. PubMed ID: 302531 [TBL] [Abstract][Full Text] [Related]
8. New insights into therapy with monoclonal antibodies in allograft transplantation. Schena FP Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230 [No Abstract] [Full Text] [Related]
9. Regulation of the immune response--what can be learnt from immunosuppressants? Turk JL Br J Clin Pract; 1986 Apr; 40(4):137-9. PubMed ID: 3488069 [No Abstract] [Full Text] [Related]
13. [Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody]. Campana C Ital Heart J Suppl; 2000 Jun; 1(6):838-9. PubMed ID: 11204021 [No Abstract] [Full Text] [Related]
14. [Is it possible to zero the immune system? Co-stimulatory blockade: experimental studies to achieve transplantation tolerance]. Aasvang EK; Egfjord M Ugeskr Laeger; 2003 Apr; 165(15):1562-5. PubMed ID: 12715660 [No Abstract] [Full Text] [Related]
15. Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice. Hori J; Yamagami S; Obata H; Tsuru T; Isobe M Transplant Proc; 1996 Jun; 28(3):1990-1. PubMed ID: 8658970 [No Abstract] [Full Text] [Related]
16. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection. Campos HH; Bach JF; Chatenoud L Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486 [No Abstract] [Full Text] [Related]
17. Unique aspects of rejection and tolerance in liver transplantation. Knechtle SJ; Kwun J Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662 [TBL] [Abstract][Full Text] [Related]
18. Is there any role for antithymocyte induction in renal transplantation? Neidlinger NA; Sollinger HW Transplant Proc; 2010 Jun; 42(5):1402-7. PubMed ID: 20620444 [TBL] [Abstract][Full Text] [Related]
19. The evolution and future of immunosuppression in renal transplantation. Goral S; Helderman JH Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720 [TBL] [Abstract][Full Text] [Related]
20. The use of monoclonal antibodies to achieve immunological tolerance. Waldmann H; Cobbold S Trends Pharmacol Sci; 1993 May; 14(5):143-8. PubMed ID: 8212308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]